WASHINGTON (Reuters) – U.S. Food and Drug Administration (FDA) Commissioner Stephen Hahn said on Friday the agency will move quickly to review a Pfizer-BioNTech coronavirus vaccine and hopes it will make a decision this month.
Hahn declined to give a specific timeline of how long an approval of Pfizer’s coronavirus vaccine would take, saying only that the FDA would move “very quickly” after a vaccine advisory committee meets on Dec. 10.
Many federal officials are expecting a vaccine approval within days of that meeting, though one FDA official recently said an approval decision could take up to weeks.
(Reporting by Julie Steenhuysen, Caroline Humer, Susan Heavey and Jeff Mason; Editing by Nick Zieminski and David Clarke)
